Clinical trial
Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese Participants
NCT07174830 is registered in ClinicalTrials.gov with Shenzhen Salubris Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese Participants
- Lead sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 6, 2025
- Completion date
- February 16, 2026
- Enrollment
- 54 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy participants